Cargando…
The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis
Myo-inositol belongs to one of the sugar alcohol groups known as cyclitols. Phosphatidylinositols are one of the derivatives of Myo-inositol, and constitute important mediators in many intracellular processes such as cell growth, cell differentiation, receptor recycling, cytoskeletal organization, a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605126/ https://www.ncbi.nlm.nih.gov/pubmed/37892232 http://dx.doi.org/10.3390/biom13101550 |
_version_ | 1785126998848307200 |
---|---|
author | Derkaczew, Maria Martyniuk, Piotr Hofman, Robert Rutkowski, Krzysztof Osowski, Adam Wojtkiewicz, Joanna |
author_facet | Derkaczew, Maria Martyniuk, Piotr Hofman, Robert Rutkowski, Krzysztof Osowski, Adam Wojtkiewicz, Joanna |
author_sort | Derkaczew, Maria |
collection | PubMed |
description | Myo-inositol belongs to one of the sugar alcohol groups known as cyclitols. Phosphatidylinositols are one of the derivatives of Myo-inositol, and constitute important mediators in many intracellular processes such as cell growth, cell differentiation, receptor recycling, cytoskeletal organization, and membrane fusion. They also have even more functions that are essential for cell survival. Mutations in genes encoding phosphatidylinositols and their derivatives can lead to many disorders. This review aims to perform an in-depth analysis of these connections. Many authors emphasize the significant influence of phosphatidylinositols and phosphatidylinositols’ phosphates in the pathogenesis of myotubular myopathies, neurodegenerative disorders, carcinogenesis, and other less frequently observed diseases. In our review, we have focused on three of the most often mentioned groups of disorders. Inositols are the topic of many studies, and yet, there are no clear results of successful clinical trials. Analysis of the available literature gives promising results and shows that further research is still needed. |
format | Online Article Text |
id | pubmed-10605126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106051262023-10-28 The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis Derkaczew, Maria Martyniuk, Piotr Hofman, Robert Rutkowski, Krzysztof Osowski, Adam Wojtkiewicz, Joanna Biomolecules Review Myo-inositol belongs to one of the sugar alcohol groups known as cyclitols. Phosphatidylinositols are one of the derivatives of Myo-inositol, and constitute important mediators in many intracellular processes such as cell growth, cell differentiation, receptor recycling, cytoskeletal organization, and membrane fusion. They also have even more functions that are essential for cell survival. Mutations in genes encoding phosphatidylinositols and their derivatives can lead to many disorders. This review aims to perform an in-depth analysis of these connections. Many authors emphasize the significant influence of phosphatidylinositols and phosphatidylinositols’ phosphates in the pathogenesis of myotubular myopathies, neurodegenerative disorders, carcinogenesis, and other less frequently observed diseases. In our review, we have focused on three of the most often mentioned groups of disorders. Inositols are the topic of many studies, and yet, there are no clear results of successful clinical trials. Analysis of the available literature gives promising results and shows that further research is still needed. MDPI 2023-10-19 /pmc/articles/PMC10605126/ /pubmed/37892232 http://dx.doi.org/10.3390/biom13101550 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Derkaczew, Maria Martyniuk, Piotr Hofman, Robert Rutkowski, Krzysztof Osowski, Adam Wojtkiewicz, Joanna The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis |
title | The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis |
title_full | The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis |
title_fullStr | The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis |
title_full_unstemmed | The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis |
title_short | The Genetic Background of Abnormalities in Metabolic Pathways of Phosphoinositides and Their Linkage with the Myotubular Myopathies, Neurodegenerative Disorders, and Carcinogenesis |
title_sort | genetic background of abnormalities in metabolic pathways of phosphoinositides and their linkage with the myotubular myopathies, neurodegenerative disorders, and carcinogenesis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605126/ https://www.ncbi.nlm.nih.gov/pubmed/37892232 http://dx.doi.org/10.3390/biom13101550 |
work_keys_str_mv | AT derkaczewmaria thegeneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT martyniukpiotr thegeneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT hofmanrobert thegeneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT rutkowskikrzysztof thegeneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT osowskiadam thegeneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT wojtkiewiczjoanna thegeneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT derkaczewmaria geneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT martyniukpiotr geneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT hofmanrobert geneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT rutkowskikrzysztof geneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT osowskiadam geneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis AT wojtkiewiczjoanna geneticbackgroundofabnormalitiesinmetabolicpathwaysofphosphoinositidesandtheirlinkagewiththemyotubularmyopathiesneurodegenerativedisordersandcarcinogenesis |